CN105770281A - Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine - Google Patents

Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine Download PDF

Info

Publication number
CN105770281A
CN105770281A CN201610319133.4A CN201610319133A CN105770281A CN 105770281 A CN105770281 A CN 105770281A CN 201610319133 A CN201610319133 A CN 201610319133A CN 105770281 A CN105770281 A CN 105770281A
Authority
CN
China
Prior art keywords
medicine
western
medicines
cholelithiasis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610319133.4A
Other languages
Chinese (zh)
Inventor
晋利华
李政
晋利红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610319133.4A priority Critical patent/CN105770281A/en
Publication of CN105770281A publication Critical patent/CN105770281A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a compositive medicine for treating cholelithiasis through the combination of traditional Chinese medicines and western medicines. The compositive medicine for treating the cholelithiasis through the combination of the traditional Chinese medicines and the western medicines comprises traditional Chinese medicinal components and western medicinal components, wherein the traditional Chinese medicinal components are 7g to 17g of herba lysimachiae, 7g to 17g of rhizoma chuanxiong, 1g to 11g of fructus aurantii immaturus, 1g to 11g of pericarpium arecae, 4g to 14g of leontopodium japonicum, 7g to 17g of radix gentianae macrophyllae, 7g to 17g of cotoneaster salicifolius, 1g to 11g of herba artemisia annua Linn and 11g to 21g of fructus toosendan; the western medicinal components are 5g to 15g of ursodesoxycholic acid and 1g to 11g of glacial acetic acid. The compositive medicine for treating the cholelithiasis through the combination of the traditional Chinese medicines and the western medicines is prepared by combining the traditional Chinese medicine with the western medicine, is stable in therapeutic effectiveness, and is used for treating both symptoms and root causes; the ursodesoxycholic acid and the glacial acetic acid in the western medicinal components can be used for quickly treating the cholelithiasis, and quickly relieving an exterior syndrome for the remission of the symptom; all medicines in the traditional Chinese medicinal components are compatible, monarch and ministerial medicines are cooperative, and adjuvant and guiding medicines are auxiliary; the compositive medicine for treating the cholelithiasis through the combination of the traditional Chinese medicines and the western medicines aims at achieving the final purpose of fundamentally treating the cholelithiasis, and meanwhile, is capable of improving the disease resistance of a human body step by step, and protecting liver.

Description

A kind of composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis
Technical field
The present invention relates to a kind of department of general surgery medicine, particularly to the composition of medicine of a kind of collaborative treatment of Chinese and western medicines cholelithiasis.
Background technology
Cholelithiasis refers to that the disease of calculus occurs at any position of biliary system (including gallbladder and bile duct), cardinal symptom is stomachache (distending pain or angor, severe pain), nausea and vomiting, fear of cold, heating and jaundice, kind and the composition of calculus are incomplete same, clinical manifestation depend on whether cause with calculus but to infecting, obstruction of biliary tract and the position blocked and degree, cholelithiasis is worldwide commonly encountered diseases, and China is no exception.In general population, the sickness rate of cholelithiasis reaches about 10%, and domestic autopsy findings is reported, the incidence rate of cholelithiasis is 7%, and female patient is common, especially fatter women, and the ratio of men and women is about 1:2.Cholelithiasis is still lacked at present to the effective medicine of generally recognized as safe.Though its reason is in that Chinese medicine can eradicate disease, but onset is slow, and Western medicine onset is very fast, but mostly is for symptom treatment, it is impossible to eradicate disease, it is easy to recurrence；And existing Chinese and western drugs coupling is because the screening selecting medicament categories is undesirable or consumption coordinates appropriate, all there is drug effect in various degree and offset even drug effect antagonism.
Summary of the invention
The technical problem to be solved in the present invention is the drawbacks described above how overcoming prior art, it is provided that the composition of medicine of a kind of collaborative treatment of Chinese and western medicines cholelithiasis.
For solving above-mentioned technical problem, the composition of medicine of this collaborative treatment of Chinese and western medicines cholelithiasis, it is characterized in that: include Chinese medicinal components and western medicine component, wherein, Chinese medicinal components is: Herba Lysimachiae 7～17g, Rhizoma Chuanxiong 7～17g, Fructus Aurantii Immaturus 1～11g, Pericarpium Arecae 1～11g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 4～14g, Radix Gentianae Macrophyllae 7～17g, Radix cotoneastri salicifolii 7～17g, QINGSONG 1～11g, Fructus Toosendan 11～21g；Western medicine component is: ursodesoxycholic acid 5～15g, glacial acetic acid 1～11g；The preparation method of described Chinese medicinal components is, Herba Lysimachiae is weighed by above-mentioned formula ratio, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae, thin snow Leontopodium leontopodioides (Willd.) Beauv., Radix Gentianae Macrophyllae, Radix cotoneastri salicifolii, the Herba Lysimachiae that 1/2nd amounts are taken, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae decocts soup, filter decoction and make diluent, the Herba Lysimachiae of other 2/3rds amounts, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae, thin snow Leontopodium leontopodioides (Willd.) Beauv., Radix Gentianae Macrophyllae, Radix cotoneastri salicifolii mixes with all the other components, the decoction adding mixture 30 times amount soaks decoction twice, about each half an hour, the decocting liquid merging twice filters, and it is concentrated into paste, dry under 60～80 DEG C of conditions, it is ground into fine powder, do binding agent with the ethanol of 80% and make 20 order granules, add after granulate granular mass 1% magnesium stearate, dried pulverizing makes powder；The preparation method of described western medicine component is, weighs ursodesoxycholic acid, glacial acetic acid by above-mentioned formula ratio, and after the two being mixed, wet granule compression tablet method makes tablet routinely.
As optimum ratio scope, described Chinese medicinal components is: Herba Lysimachiae 11～13g, Rhizoma Chuanxiong 11～13g, Fructus Aurantii Immaturus 5～7g, Pericarpium Arecae 5～7g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 8～10g, Radix Gentianae Macrophyllae 11～13g, Radix cotoneastri salicifolii 11～13g, QINGSONG 5～7g, Fructus Toosendan 15～17g；Described western medicine component is: ursodesoxycholic acid 9～11g, glacial acetic acid 5～7g.
As optimum ratio, described Chinese medicinal components is: Herba Lysimachiae 17g, Rhizoma Chuanxiong 7g, Fructus Aurantii Immaturus 11g, Pericarpium Arecae 1g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 14g, Radix Gentianae Macrophyllae 7g, Radix cotoneastri salicifolii 17g, QINGSONG 11g, Fructus Toosendan 11g；Described western medicine component is: ursodesoxycholic acid 15g, glacial acetic acid 1g.
As optimum ratio, described Chinese medicinal components is: Herba Lysimachiae 7g, Rhizoma Chuanxiong 17g, Fructus Aurantii Immaturus 1g, Pericarpium Arecae 11g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 4g, Radix Gentianae Macrophyllae 17g, Radix cotoneastri salicifolii 7g, QINGSONG 1g, Fructus Toosendan 21g；Described western medicine component is: ursodesoxycholic acid 5g, glacial acetic acid 11g.
As it is preferred that proportioning, Herba Lysimachiae 13g, Rhizoma Chuanxiong 11g, Fructus Aurantii Immaturus 7g, Pericarpium Arecae 5g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 10g, Radix Gentianae Macrophyllae 11g, Radix cotoneastri salicifolii 13g, QINGSONG 7g, Fructus Toosendan 15g；Described western medicine component is: ursodesoxycholic acid 11g, glacial acetic acid 5g.
As it is preferred that proportioning, Herba Lysimachiae 11g, Rhizoma Chuanxiong 13g, Fructus Aurantii Immaturus 5g, Pericarpium Arecae 7g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 8g, Radix Gentianae Macrophyllae 13g, Radix cotoneastri salicifolii 11g, QINGSONG 5g, Fructus Toosendan 17g；Described western medicine component is: ursodesoxycholic acid 9g, glacial acetic acid 7g.
As optimization formula amount, Herba Lysimachiae 12g, Rhizoma Chuanxiong 12g, Fructus Aurantii Immaturus 6g, Pericarpium Arecae 6g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 9g, Radix Gentianae Macrophyllae 12g, Radix cotoneastri salicifolii 12g, QINGSONG 6g, Fructus Toosendan 16g；Described western medicine component is: ursodesoxycholic acid 10g, glacial acetic acid 6g.
Using method:
Chinese medicine and western medicine is every day three times morning, noon and afternoon, and Chinese medicine is 2g each serving consumption, and Western medicine is 0.5g each serving consumption, and Western medicine first takes, and is taking Chinese medicine after 40 minutes
Pharmacology analysis
Herba Lysimachiae: cold nature is sweet in the mouth, salty；Return liver, gallbladder, kidney, bladder warp；Clearing away heat-damp and promoting diuresis, treating stranguria, detumescence；For pyretic stranguria, sand Stranguria, urine is puckery has a pain, jaundice dark coloured urine, carbuncle furuncle, venom, liver and bile stone, lithangiuria.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature；Return liver, gallbladder, heart channel；Blood-activating and qi-promoting, wind-expelling pain-stopping.
Fructus Aurantii Immaturus: bitter in the mouth, cold in nature；Return liver, gallbladder meridian；Eliminating pathogen in the liver gallbladder excess-fire, except damp-heat in lower-JIAO.
Pericarpium Arecae: acrid in the mouth, slightly warm in nature；Return spleen, stomach, large intestine, small intestine meridian；Return spleen, stomach warp；For retention of damp leading to blockage of QI, gastral cavity abdominal distention is vexed, defecates not well, edema distension, beriberi edema, dysuria.
Thin snow Leontopodium leontopodioides (Willd.) Beauv.: taste is micro-sweet, and property is put down；Return bladder, the heart, lung meridian；Diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI in the collateral by warming the meridian.
Radix Gentianae Macrophyllae: acrid in the mouth, hardship, cold nature；Return stomach, liver, gallbladder meridian；Rheumatism, relaxing muscles and tendons network, clearind deficient heat, clearing away damp-heat.
Radix cotoneastri salicifolii: bitter in the mouth, pungent, cold nature；Return spleen, stomach, liver, gallbladder meridian；Eliminating damp-heat, promoting the function of the gallbladder to alleviate jaundice.
QINGSONG: acrid in the mouth, hardship, warm in nature；Return spleen, large intestine, tri-jiao channel；Circulation of qi promoting, pain relieving, spleen invigorating, help digestion, promoting the circulation of QI to relieve pain, adjust in intestinal stasis relieving.
Fructus Toosendan: acrid in the mouth, hardship, warm in nature；GUIXIN, liver, spleen channel；Regulating qi and activating blood, fixed logical, chase after effect of poison.
The composition of medicine of a kind of collaborative treatment of Chinese and western medicines cholelithiasis of the present invention is prepared by the combination of Chinese and Western medicine, stable curative effect, treating both the principal and secondary aspects of a disease, taking convenience is simple and avirulence side effect, safe and reliable, in western medicine component, ursodesoxycholic acid, glacial acetic acid can make quick reply for cholelithiasis, quickly induce sweat relief of symptoms, and Chinese medicinal components is with Herba Lysimachiae, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae for monarch drug；With thin snow Leontopodium leontopodioides (Willd.) Beauv., Radix Gentianae Macrophyllae, Radix cotoneastri salicifolii for ministerial drug, formulated with QINGSONG, Fructus Toosendan for adjuvant；All medicine compatibilities in side, the monarch and his subjects pull together, help make auxiliary altogether, it is intended to fundamentally treatment cholelithiasis is final purpose, can step up human disease resistance, the liver protecting simultaneously.
Detailed description of the invention
nullEmbodiment 1: by Herba Lysimachiae 17g、Rhizoma Chuanxiong 7g、Fructus Aurantii Immaturus 11g、Pericarpium Arecae 1g、Thin snow Leontopodium leontopodioides (Willd.) Beauv. 14g、Radix Gentianae Macrophyllae 7g、Radix cotoneastri salicifolii 17g、QINGSONG 11g、The formula ratio of Fructus Toosendan 11g weighs Herba Lysimachiae、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii，The Herba Lysimachiae that 1/2nd amounts are taken、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae decocts soup，Filter decoction and make diluent，The Herba Lysimachiae of other 1/2nd amounts、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii mixes with all the other components，The decoction adding mixture 30 times amount soaks decoction twice，About each half an hour，The decocting liquid merging twice filters，And it is concentrated into paste，Dry under 60～80 DEG C of conditions，It is ground into fine powder，Do binding agent with the ethanol of 80% and make 20 order granules，Add after granulate granular mass 1% magnesium stearate，Dried pulverizing makes powder；
Weighing ursodesoxycholic acid, glacial acetic acid by the formula ratio of ursodesoxycholic acid 15g, glacial acetic acid 1g, after the two being mixed, wet granule compression tablet method makes tablet routinely.
nullEmbodiment 2: by Herba Lysimachiae 7g、Rhizoma Chuanxiong 17g、Fructus Aurantii Immaturus 1g、Pericarpium Arecae 11g、Thin snow Leontopodium leontopodioides (Willd.) Beauv. 4g、Radix Gentianae Macrophyllae 17g、Radix cotoneastri salicifolii 7g、QINGSONG 1g、The formula ratio of Fructus Toosendan 21g weighs Herba Lysimachiae、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii，The Herba Lysimachiae that 1/2nd amounts are taken、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae decocts soup，Filter decoction and make diluent，The Herba Lysimachiae of other 1/2nd amounts、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii mixes with all the other components，The decoction adding mixture 30 times amount soaks decoction twice，About each half an hour，The decocting liquid merging twice filters，And it is concentrated into paste，Dry under 60～80 DEG C of conditions，It is ground into fine powder，Do binding agent with the ethanol of 80% and make 20 order granules，Add after granulate granular mass 1% magnesium stearate，Dried pulverizing makes powder；
Weighing ursodesoxycholic acid, glacial acetic acid by the formula ratio of ursodesoxycholic acid 5g, glacial acetic acid 11g, after the two being mixed, wet granule compression tablet method makes tablet routinely.
nullEmbodiment 3: by Herba Lysimachiae 13g、Rhizoma Chuanxiong 11g、Fructus Aurantii Immaturus 7g、Pericarpium Arecae 5g、Thin snow Leontopodium leontopodioides (Willd.) Beauv. 10g、Radix Gentianae Macrophyllae 11g、Radix cotoneastri salicifolii 13g、QINGSONG 7g、The formula ratio of Fructus Toosendan 15g weighs Herba Lysimachiae、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii，The Herba Lysimachiae that 1/2nd amounts are taken、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae decocts soup，Filter decoction and make diluent，The Herba Lysimachiae of other 1/2nd amounts、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii mixes with all the other components，The decoction adding mixture 30 times amount soaks decoction twice，About each half an hour，The decocting liquid merging twice filters，And it is concentrated into paste，Dry under 60～80 DEG C of conditions，It is ground into fine powder，Do binding agent with the ethanol of 80% and make 20 order granules，Add after granulate granular mass 1% magnesium stearate，Dried pulverizing makes powder；
Weighing ursodesoxycholic acid, glacial acetic acid by the formula ratio of ursodesoxycholic acid 5g, glacial acetic acid 11g, after the two being mixed, wet granule compression tablet method makes tablet routinely.
nullEmbodiment 4: by Herba Lysimachiae 13g、Rhizoma Chuanxiong 11g、Fructus Aurantii Immaturus 7g、Pericarpium Arecae 5g、Thin snow Leontopodium leontopodioides (Willd.) Beauv. 10g、Radix Gentianae Macrophyllae 11g、Radix cotoneastri salicifolii 13g、QINGSONG 7g、The formula ratio of Fructus Toosendan 15g weighs Herba Lysimachiae、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii，The Herba Lysimachiae that 1/2nd amounts are taken、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae decocts soup，Filter decoction and make diluent，The Herba Lysimachiae of other 1/2nd amounts、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii mixes with all the other components，The decoction adding mixture 30 times amount soaks decoction twice，About each half an hour，The decocting liquid merging twice filters，And it is concentrated into paste，Dry under 60～80 DEG C of conditions，It is ground into fine powder，Do binding agent with the ethanol of 80% and make 20 order granules，Add after granulate granular mass 1% magnesium stearate，Dried pulverizing makes powder；
Weighing ursodesoxycholic acid, glacial acetic acid by the formula ratio of ursodesoxycholic acid 5g, glacial acetic acid 11g, after the two being mixed, wet granule compression tablet method makes tablet routinely.
nullEmbodiment 5: by Herba Lysimachiae 13g、Rhizoma Chuanxiong 11g、Fructus Aurantii Immaturus 7g、Pericarpium Arecae 5g、Thin snow Leontopodium leontopodioides (Willd.) Beauv. 10g、Radix Gentianae Macrophyllae 11g、Radix cotoneastri salicifolii 13g、QINGSONG 7g、The formula ratio of Fructus Toosendan 15g weighs Herba Lysimachiae、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii，The Herba Lysimachiae that 1/2nd amounts are taken、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae decocts soup，Filter decoction and make diluent，The Herba Lysimachiae of other 1/2nd amounts、Rhizoma Chuanxiong、Fructus Aurantii Immaturus、Pericarpium Arecae、Thin snow Leontopodium leontopodioides (Willd.) Beauv.、Radix Gentianae Macrophyllae、Radix cotoneastri salicifolii mixes with all the other components，The decoction adding mixture 30 times amount soaks decoction twice，About each half an hour，The decocting liquid merging twice filters，And it is concentrated into paste，Dry under 60～80 DEG C of conditions，It is ground into fine powder，Do binding agent with the ethanol of 80% and make 20 order granules，Add after granulate granular mass 1% magnesium stearate，Dried pulverizing makes powder；
Weighing ursodesoxycholic acid, glacial acetic acid by the formula ratio of ursodesoxycholic acid 5g, glacial acetic acid 11g, after the two being mixed, wet granule compression tablet method makes tablet routinely.
Wherein, the composition of medicine decoction E clinical application effect of the collaborative treatment of Chinese and western medicines cholelithiasis of embodiment 5 preparation is best, therefore is embodiment 5 most preferred embodiment.
Clinical data
600 example patients are carried out Ureteral Calculus, and cholelithiasis sufferer is had original curative effect by the medicine to prove the present invention,
The cholelithiasis course of disease Case Cure Effective Effectively Invalid Effective percentage
In the cholelithiasis course of disease one week 300 90 200 290 10 96.67%
In cholelithiasis course of disease January 300 60 190 250 50 83.33%
All cases patient clinical is observed and is had no any untoward reaction.
In sum, the composition of medicine of a kind of collaborative treatment of Chinese and western medicines of present invention cholelithiasis is effective and safe drugs.
Above-mentioned embodiment is intended to illustrate that the present invention can realize for professional and technical personnel in the field or use; above-mentioned embodiment is modified and will be apparent from for those skilled in the art; therefore the present invention includes but not limited to above-mentioned embodiment; any present claims book or description of meeting describes; meet and principles disclosed herein and novelty, the method for inventive features, technique, product, each fall within protection scope of the present invention.

Claims (7)

1. a composition of medicine for collaborative treatment of Chinese and western medicines cholelithiasis, is characterized in that: include Chinese medicinal components and western medicine component, wherein,
Chinese medicinal components is: Herba Lysimachiae 7～17g, Rhizoma Chuanxiong 7～17g, Fructus Aurantii Immaturus 1～11g, Pericarpium Arecae 1～11g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 4～14g, Radix Gentianae Macrophyllae 7～17g, Radix cotoneastri salicifolii 7～17g, QINGSONG 1～11g, Fructus Toosendan 11～21g；
Western medicine component is: ursodesoxycholic acid 5～15g, glacial acetic acid 1～11g；
The preparation method of described Chinese medicinal components is, Herba Lysimachiae is weighed by above-mentioned formula ratio, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae, thin snow Leontopodium leontopodioides (Willd.) Beauv., Radix Gentianae Macrophyllae, Radix cotoneastri salicifolii, the Herba Lysimachiae that 1/2nd amounts are taken, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae decocts soup, filter decoction and make diluent, the Herba Lysimachiae of other 1/2nd amounts, Rhizoma Chuanxiong, Fructus Aurantii Immaturus, Pericarpium Arecae, thin snow Leontopodium leontopodioides (Willd.) Beauv., Radix Gentianae Macrophyllae, Radix cotoneastri salicifolii mixes with all the other components, the decoction adding mixture 30 times amount soaks decoction twice, about each half an hour, the decocting liquid merging twice filters, and it is concentrated into paste, dry under 60～80 DEG C of conditions, it is ground into fine powder, do binding agent with the ethanol of 80% and make 20 order granules, add after granulate granular mass 1% magnesium stearate, dried pulverizing makes powder；
The preparation method of described western medicine component is, weighs ursodesoxycholic acid, glacial acetic acid by above-mentioned formula ratio, and after the two being mixed, wet granule compression tablet method makes tablet routinely.
2. the composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis according to claim 1, is characterized in that: described Chinese medicinal components is: Herba Lysimachiae 11～13g, Rhizoma Chuanxiong 11～13g, Fructus Aurantii Immaturus 5～7g, Pericarpium Arecae 5～7g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 8～10g, Radix Gentianae Macrophyllae 11～13g, Radix cotoneastri salicifolii 11～13g, QINGSONG 5～7g, Fructus Toosendan 15～17g；Described western medicine component is: ursodesoxycholic acid 9～11g, glacial acetic acid 5～7g.
3. the composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis according to claim 1, is characterized in that: described Chinese medicinal components is: Herba Lysimachiae 17g, Rhizoma Chuanxiong 7g, Fructus Aurantii Immaturus 11g, Pericarpium Arecae 1g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 14g, Radix Gentianae Macrophyllae 7g, Radix cotoneastri salicifolii 17g, QINGSONG 11g, Fructus Toosendan 11g；Described western medicine component is: ursodesoxycholic acid 15g, glacial acetic acid 1g.
4. the composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis according to claim 1, is characterized in that: described Chinese medicinal components is: Herba Lysimachiae 7g, Rhizoma Chuanxiong 17g, Fructus Aurantii Immaturus 1g, Pericarpium Arecae 11g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 4g, Radix Gentianae Macrophyllae 17g, Radix cotoneastri salicifolii 7g, QINGSONG 1g, Fructus Toosendan 21g；Described western medicine component is: ursodesoxycholic acid 5g, glacial acetic acid 11g.
5. the composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis according to claim 2, is characterized in that: described Chinese medicinal components is: Herba Lysimachiae 13g, Rhizoma Chuanxiong 11g, Fructus Aurantii Immaturus 7g, Pericarpium Arecae 5g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 10g, Radix Gentianae Macrophyllae 11g, Radix cotoneastri salicifolii 13g, QINGSONG 7g, Fructus Toosendan 15g；Described western medicine component is: ursodesoxycholic acid 11g, glacial acetic acid 5g.
6. the composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis according to claim 2, is characterized in that: described Chinese medicinal components is: Herba Lysimachiae 11g, Rhizoma Chuanxiong 13g, Fructus Aurantii Immaturus 5g, Pericarpium Arecae 7g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 8g, Radix Gentianae Macrophyllae 13g, Radix cotoneastri salicifolii 11g, QINGSONG 5g, Fructus Toosendan 17g；Described western medicine component is: ursodesoxycholic acid 9g, glacial acetic acid 7g.
7. the composition of medicine of collaborative treatment of Chinese and western medicines cholelithiasis according to claim 2, is characterized in that: described Chinese medicinal components is: Herba Lysimachiae 12g, Rhizoma Chuanxiong 12g, Fructus Aurantii Immaturus 6g, Pericarpium Arecae 6g, thin snow Leontopodium leontopodioides (Willd.) Beauv. 9g, Radix Gentianae Macrophyllae 12g, Radix cotoneastri salicifolii 12g, QINGSONG 6g, Fructus Toosendan 16g；Described western medicine component is: ursodesoxycholic acid 10g, glacial acetic acid 6g.
CN201610319133.4A 2016-05-13 2016-05-13 Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine Pending CN105770281A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610319133.4A CN105770281A (en) 2016-05-13 2016-05-13 Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610319133.4A CN105770281A (en) 2016-05-13 2016-05-13 Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine

Publications (1)

Publication Number Publication Date
CN105770281A true CN105770281A (en) 2016-07-20

Family

ID=56379789

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610319133.4A Pending CN105770281A (en) 2016-05-13 2016-05-13 Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine

Country Status (1)

Country Link
CN (1) CN105770281A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586602A (en) * 2004-07-30 2005-03-02 梅喜 Medicinal composition for treating cholelithiasis and its preparing method
CN103830577A (en) * 2014-03-25 2014-06-04 崔新明 Medicine composition for treating liver and gall calculus and kidney stone and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586602A (en) * 2004-07-30 2005-03-02 梅喜 Medicinal composition for treating cholelithiasis and its preparing method
CN103830577A (en) * 2014-03-25 2014-06-04 崔新明 Medicine composition for treating liver and gall calculus and kidney stone and application thereof

Similar Documents

Publication Publication Date Title
CN101884770B (en) Chinese medicinal preparation for treating urolithiasis and preparation method thereof
CN103099959B (en) Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof
CN101019984B (en) Constipation treating Chinese medicine preparation
CN101972443B (en) Chinese medicinal formula for treating chronic gastritis
CN101129994A (en) Traditional Chinese medicine composition for treating icterus
CN102293860B (en) Traditional Chinese medicine for treating diarrhea
CN103735721B (en) A kind of Chinese medicine treating pink-eye
CN103977366A (en) Medicine for treating chronic cholecystitis
CN103751290B (en) One treats psoriatic pharmaceutical composition
CN101926903A (en) Chinese medicine preparation for curing facial paralysis
CN102727676A (en) Traditional Chinese herbal composition for treating allergic purpura as well as preparation method and application thereof
CN103211946B (en) Traditional Chinese medicine for treating gastric ulcer and duodenal ulcer
CN105770281A (en) Compositive medicine for treating cholelithiasis through combination of traditional Chinese medicine and western medicine
CN105535331A (en) External ointment for treating cervical erosion and preparation method of external ointment
CN104800675A (en) Medicament for treating active ulcerative colitis
CN104689239A (en) Traditional Chinese medicine composition for treating cholelithiasis and preparation method thereof
CN104435641A (en) Traditional Chinese medicine preparation for treating hyperthyroidism
CN104027430A (en) Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN103520638B (en) A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof
CN101961481A (en) Traditional Chinese medicine for treating liver-gallbladder qi stagnation type cholecystitis and preparation method thereof
CN105232609A (en) Traditional Chinese medicine combination treating functional dyspepsia
CN106728189B (en) Traditional Chinese medicine for treating functional constipation of children and preparation method thereof
CN105726861A (en) Combined medicine for treating chronic gastritis through combination of traditional Chinese medicines and Western medicines
CN104825980A (en) Traditional Chinese medicine preparation for treating diarrhea
CN105169111A (en) Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160720

RJ01 Rejection of invention patent application after publication